Immune checkpoint inhibitors (like PD‐1/PD‐L1 inhibitors) have shown efficacy in some endometrial cancer patients, particularly those with high microsatellite instability (MSI‐H) tumours. The gene discussed is CD274; the disease is neoplasm.